Literature DB >> 16317686

Roles of AKT and sphingosine kinase in the antiapoptotic effects of bile duct ligation in mouse liver.

Yosuke Osawa1, Yusuf A Hannun, Richard L Proia, David A Brenner.   

Abstract

Tumor necrosis factor (TNF) receptor- and Fas-mediated apoptosis are major death processes of hepatocytes in liver disease. Although antiapoptotic effects in the injured liver promote chronic hepatitis and carcinogenesis, scant information is known about these mechanisms. To explore this issue, we compared acute liver injury after TNF-alpha or anti-Fas antibody (Jo2) between livers from sham-operated mice and chronic injured liver via bile duct ligation (BDL). BDL inhibited hepatocyte apoptosis induced by TNF-alpha but not by Jo2. On the other hand, BDL inhibited the massive hemorrhage seen in livers treated with either TNF-alpha or Jo2. Inactivation of AKT blocked the antiapoptotic effect of BDL. Sphingosine kinase knockout mice also lost the antihemorrhagic effect of BDL and attenuated the antiapoptotic effects of BDL. In bile duct-ligated livers, hepatic stellate cells (HSCs) were activated and produced tissue inhibitor of metalloproteinase 1 in a sphingosine kinase (SphK)-1-dependent mechanism. In conclusion, BDL exerts antiapoptotic effects that appear to require activation of AKT in hepatocytes and SphK in HSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317686     DOI: 10.1002/hep.20967

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.

Authors:  Yosuke Osawa; Atsushi Suetsugu; Rie Matsushima-Nishiwaki; Ichiro Yasuda; Toshiji Saibara; Hisataka Moriwaki; Mitsuru Seishima; Osamu Kozawa
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

2.  Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse.

Authors:  P Georgiev; A A Navarini; J J Eloranta; K S Lang; G A Kullak-Ublick; A Nocito; F Dahm; W Jochum; R Graf; P-A Clavien
Journal:  Gut       Date:  2006-06-08       Impact factor: 23.059

3.  The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury.

Authors:  Kun Wang; Ivan Damjanov; Yu-Jui Yvonne Wan
Journal:  Lab Invest       Date:  2009-12-07       Impact factor: 5.662

4.  The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.

Authors:  Sven Schüngel; Laura Elisa Buitrago-Molina; Padmavathi devi Nalapareddy; Margitta Lebofsky; Michael P Manns; Hartmut Jaeschke; Atan Gross; Arndt Vogel
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

5.  Hydrophobic bile acid apoptosis is regulated by sphingosine-1-phosphate receptor 2 in rat hepatocytes and human hepatocellular carcinoma cells.

Authors:  Cynthia R L Webster; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-17       Impact factor: 4.052

6.  Decrease of Tau hyperphosphorylation by 17β estradiol requires sphingosine kinase in a glutamate toxicity model.

Authors:  Alejandro Lopez-Tobón; Efraín Cepeda-Prado; Gloria Patricia Cardona-Gómez
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

7.  β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein.

Authors:  Deling Yin; Xiaohua Yang; Hui Li; Huimin Fan; Xiaoli Zhang; Yimin Feng; Charles Stuart; Dan Hu; Yi Caudle; Nanchang Xie; Zhongmin Liu; Gene LeSage
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

8.  Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression.

Authors:  Yosuke Osawa; Ekihiro Seki; Yuzo Kodama; Atsushi Suetsugu; Kouichi Miura; Masayuki Adachi; Hiroyasu Ito; Yoshimune Shiratori; Yoshiko Banno; Jerrold M Olefsky; Masahito Nagaki; Hisataka Moriwaki; David A Brenner; Mitsuru Seishima
Journal:  FASEB J       Date:  2010-12-16       Impact factor: 5.191

9.  L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin.

Authors:  Yosuke Osawa; Hiromitsu Kanamori; Ekihiro Seki; Masato Hoshi; Hirofumi Ohtaki; Yoichi Yasuda; Hiroyasu Ito; Atsushi Suetsugu; Masahito Nagaki; Hisataka Moriwaki; Kuniaki Saito; Mitsuru Seishima
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

10.  Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.

Authors:  Yosuke Osawa; Masato Hoshi; Ichiro Yasuda; Toshiji Saibara; Hisataka Moriwaki; Osamu Kozawa
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.